Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Peng Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6714-7424; OpenAlex author ID A5101930775. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 1 paper

Papers 7

  1. Tumor-derived exosomal long noncoding RNA LINC01133, regulated by Periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition … Co-author DOI 10.1038/s41388-021-01762-0↗
  2. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer. First author DOI 10.1007/s13577-020-00401-2↗
  3. The Long-Term Fate of the Sonoporated Pancreatic Cancer Cells is Uncorrelated With the Degree of Model Molecular Loading. Last author DOI 10.1016/j.ultrasmedbio.2019.10.026↗
  4. UTMD-Promoted Co-Delivery of Gemcitabine and miR-21 Inhibitor by Dendrimer-Entrapped Gold Nanoparticles for Pancreatic Cancer Therapy. Co-author DOI 10.7150/thno.22834↗
  5. Role of microenvironmental periostin in pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.11533↗
  6. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5321-6↗
  7. Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Co-author DOI 10.18632/oncotarget.9512↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fan Li · 6 shared papers, 2016–2021 · strength 0.53
  2. Lizhou Lin · 5 shared papers, 2016–2020 · strength 0.38
  3. Feng Gao · 4 shared papers, 2016–2018 · strength 0.25
  4. Lianfang Du · 2 shared papers, 2018–2020 · strength 0.21
  5. Lingxi Xing · 3 shared papers, 2016–2017 · strength 0.17
  6. Lianfang Du · 3 shared papers, 2016–2017 · strength 0.17
  7. Jiajie Zhang · 3 shared papers, 2016–2017 · strength 0.17
  8. Yang Liu · 1 shared paper, 2020 · strength 0.15
  9. Lianfang Du · 1 shared paper, 2020 · strength 0.15
  10. Yang Liu · 1 shared paper, 2021 · strength 0.13
  11. Xiangyang Shi · 1 shared paper, 2018 · strength 0.08
  12. Dan Li · 1 shared paper, 2018 · strength 0.08
  13. Yang Liu · 1 shared paper, 2017 · strength 0.06
  14. Yang Liu · 1 shared paper, 2016 · strength 0.05
  15. Liu Yang · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.